Jesse Wayne Hall

CIK: 0002065269

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACRS

Aclaris Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ACRS
Aclaris Therapeutics, Inc.
May 1, 2026
Exercise(M)
Direct
36.4K shares-
ACRS
Aclaris Therapeutics, Inc.
May 1, 2026
Tax Payment(F)
Direct
9.3K shares at avg. $4.41$41K
ACRS
Aclaris Therapeutics, Inc.
Feb 2, 2026
Award(A)
Restricted Stock Units
Direct
98.1K shares-
ACRS
Aclaris Therapeutics, Inc.
Feb 2, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
343.3K shares-
ACRS
Aclaris Therapeutics, Inc.
May 1, 2025
Award(A)
Restricted Stock Units
Direct
145.5K shares-
ACRS
Aclaris Therapeutics, Inc.
May 1, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
510K shares-

		Type	Shares	Price		Ownership
May 1, 2026	ACRS Aclaris Therapeutics, Inc.	Exercise(M)	36,375	-	$0	Direct
May 1, 2026	ACRS Aclaris Therapeutics, Inc.	Tax Payment(F)	9,330	$4.41	$41,145	Direct
Feb 2, 2026	ACRS Aclaris Therapeutics, Inc.	Award(A) Restricted Stock Units	98,100	-	-	Direct
Feb 2, 2026	ACRS Aclaris Therapeutics, Inc.	Award(A) Employee Stock Option (Right to Buy)	343,300	-	-	Direct
May 1, 2025	ACRS Aclaris Therapeutics, Inc.	Award(A) Restricted Stock Units	145,500	-	-	Direct
May 1, 2025	ACRS Aclaris Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	510,000	-	-	Direct

1-6 of 6 transactions

About Hall Jesse Wayne

Hall Jesse Wayne (SEC CIK 0002065269) files insider reports with the SEC as Chief Medical Officer of Aclaris Therapeutics, Inc. (ACRS).

Signal8 holds 4 ownership filings by Hall Jesse Wayne (1 Form 3, 3 Form 4), filed between May 5, 2025 and May 5, 2026. Those filings report 6 transactions, from May 1, 2025 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hall Jesse Wayne's filings is in WAYNE, PA.

Recent filings by Hall Jesse Wayne

May 1, 2026: Option exercise of ACRS shares (Form 4, code M).
May 1, 2026: Tax withholding of ACRS shares (Form 4, code F).
Feb 2, 2026: Grants or awards of ACRS derivative securities (2 lines, Form 4, code A).
May 1, 2025: Grants or awards of ACRS derivative securities (2 lines, Form 4, code A).

Other insiders filing for Aclaris Therapeutics, Inc. (ACRS)

Kolbeck Roland Wilhelm, Chief Scientific Officer
SCHIFF ANDREW N, Director
Mehra Anand, Director
Molineaux Christopher P., Director
Humphries William D., Director
MILANO VINCENT, Director

How to read Form 4 transaction codes